Impact of Cryogenic Treatment on HCF and FCP Performance of β-Solution Treated Ti-6Al-4V ELI Biomaterial.

The poor fatigue strength of Ti-6Al-4V ELI is a main cause of failure in structural implants. In this work, Ti-6Al-4V ELI was subjected to β-solution treatment to obtain martensite microstructure and further subjected to -196 °C for 24 h. Significant improvement in high cycle fatigue performance of martensite Ti-6Al-4V ELI was observed on exposure to cryogenic cycle. Resistance to fatigue crack growth of alloy was augmented in martensite structure as compared with mill annealed sample and the same was retained even after exposure to cryogenic treatment. The variation observed in fatigue behavior due to cryogenic treatment was correlated with fractography and metallurgical investigations. Improvement in high cycle fatigue performance can be attributed to a combined effect of a decrease in the size of prior β grain, formation of massive α patch and its subsequent transformation into ultra-fine α and β during the soaking period at -196 °C.